NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Imjudo & Imfinzi PMS

RecruitingN/A

Sponsor: AstraZeneca

Conditions: Hepatocellular Carcinoma

Countries: South Korea

Based on the re-review of new drugs article, Korean pharmaceutical act, the objectives of this study are to assess safety and effectiveness of the study drugs(Imjudo \& Imfinzi) in a real world setting in patients who treated according to the approved indications in Korea.

Eligibility overview

Sex: ALL

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion criteria:

1. Patients eligible for the study drugs according to the approved label in Korea
2. Provision of signed and dated written informed consent by the patient or legally acceptable representative

Exclusion criteria:

1. Other off-label indications according to the approved label in South Korea
2. Current participation in any interventional trial

Locations (6)

Busan, South Korea
Goyang, South Korea
Seongnam, South Korea
Seoul, South Korea
Seoul, South Korea
Suwon, South Korea